EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Biocatalyst for Enantioselective Hydrazone Reduction

Amy E Hutton iD, Fei Zhao, Elizabeth Ho, Jack Domenech, Vanessa Harawa, Murray J B Brown, Gideon Grogan, Phillip D Clayman, Nicholas J Turner, Anthony P Green iD

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202424350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Amy E Hutton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Manchester Institute of Biotechnology and Department of Chemistry, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. Hauptthemen laut MEDLINE: Hydrazones, Protein Engineering, Oxidoreductases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Future Biomanufacturing Hub, Henry Royce Institute for Advanced Materials, EPSRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enantioselective reduction of hydrazones provides a convergent and versatile route to synthesize hydrazine‐containing motifs that are commonly found in pharmaceuticals and agrochemicals. However, current methods require the use of precious metals, costly chiral ligands, and/or forcing reaction conditions. Here, we report the development of a biocatalytic approach for enantioselective hydrazone reduction using engineered imine reductases. Following evaluation of an in‐house panel of >400 IRED sequences, we identified a single IR361 I127F L179V variant that promotes reduction of Cbz‐protected hydrazones. The introduction of additional two mutations via directed evolution afforded HRED1.1 that is 20‐fold more active than the parent template and promotes reduction of a variety of protected hydrazones in high yields and selectivities (>99% e.e .), including in preparative scale biotransformations. Structural analysis of HRED1.1 provides insights into the origins of its unique hydrazone reductase activity. This study offers a powerful biocatalytic route to synthesize valuable chiral hydrazine products and further expands the impressive range of transformations accessible with engineered imine reductases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrazonesProtein EngineeringOxidoreductasesStereoisomerismBiocatalysisOxidation-ReductionMolecular Structure

Stichwörter der Autor:innen

BiocatalysisDirected evolutionHydrazinesOxidoreductasesProtein engineering

Substanzen

HydrazonesOxidoreductases

Autor:innen und Institutionen

  • Manchester Institute of Biotechnology and Department of Chemistry, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
  • Disyn Biotec Ltd., 33 Matlock Close, Great Sankey, Warrington, England, WA5 3PZ, UK.
  • Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
  • GSK, Medicine Development & Supply, GSK, GSK Medicines Research Centre, Stevenage, SG1 2NY, UK.
  • GSK, Medicine Development & Supply, GSK, Collegeville, PA, USA.

ORCID-Profile: Amy E Hutton, Anthony P Green

Förderung

  • Future Biomanufacturing Hub
  • Henry Royce Institute for Advanced Materials
  • EPSRC
  • Manchester SYNBIOCHEM Centre
  • Engineering and Physical Sciences Research Council

Zitieren

APA

Hutton, A. E., Zhao, F., Ho, E., Domenech, J., Harawa, V., Brown, M. J. B., Grogan, G., Clayman, P. D., Turner, N. J., & Green, A. P. (2025). Engineered Biocatalyst for Enantioselective Hydrazone Reduction. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202424350

Vancouver

Hutton AE, Zhao F, Ho E, Domenech J, Harawa V, Brown MJB, et al. Engineered Biocatalyst for Enantioselective Hydrazone Reduction. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202424350

BibTeX
@article{Hutton2025,
  author = {Hutton, Amy E and Zhao, Fei and Ho, Elizabeth and Domenech, Jack and Harawa, Vanessa and Brown, Murray J B and Grogan, Gideon and Clayman, Phillip D and Turner, Nicholas J and Green, Anthony P},
  title = {Engineered Biocatalyst for Enantioselective Hydrazone Reduction},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202424350}
}
Kostenlos starten →